This study indicated that the low dose of BUT participated in taurine and hypotaurine metabolism by reducing the level of hypotaurine and inhibiting the release of TGF-β inflammatory factors and fibroblasts, which have anti-inflammatory and antioxidant functions, and thereby ameliorate the degree of PF. The gene discussed is TGFB1; the disease is pemphigus foliaceus.